DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Nucleotide Excision Repair
Nucleotide Excision Repair
Overview of DNA Repair
Overview of DNA Repair
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 13, 2025

Author Spotlight: Combining Proximity Ligand Assay with Gamma-H2AX Staining to Characterize Protein Interactions in DNA Damage Response
Published on: August 2, 2024
1Division of Life Science, Center for Cancer Research, State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong.
This review explores how Aurora kinases, proteins typically known for managing cell division, also play significant roles in detecting and repairing genetic damage. The authors discuss how these kinases interact with various checkpoints and repair mechanisms to maintain genomic stability. By understanding these non-mitotic functions, researchers may better utilize kinase inhibitors alongside traditional cancer treatments.
Area of Science:
Background:
No prior work has fully resolved the diverse roles of Aurora kinases beyond their traditional mitotic duties. It was already known that these proteins manage cell division cycles. That uncertainty drove interest in their secondary functions. Prior research has shown that these kinases influence genetic integrity. This gap motivated a closer look at their involvement in cellular stress. Scientists have long suspected these proteins interact with various signaling pathways. That realization prompted investigations into their broader biological impact. Current literature highlights a complex network of interactions involving these kinases.
Purpose Of The Study:
The aim of this review is to synthesize evidence regarding the non-mitotic functions of Aurora kinases in DNA damage response. Researchers sought to address the lack of a comprehensive overview of these secondary roles. This study investigates how these proteins interact with various cell cycle checkpoints. The authors intended to highlight the connection between kinase activity and genetic repair pathways. They explored the implications of kinase dysregulation for genomic integrity. This work addresses the need to understand how cells respond to genetic stress. The authors aimed to provide a rationale for future therapeutic research. This effort clarifies the multifaceted nature of these proteins in cellular biology.
Main Methods:
The authors conducted a comprehensive synthesis of current literature regarding kinase signaling. They evaluated peer-reviewed studies to identify non-mitotic roles of these proteins. This review approach prioritized evidence linking kinases to genetic repair. Investigators categorized findings based on specific cell cycle checkpoints. They analyzed data concerning p53 and p73 pathway interactions. The team examined reports on the synergy between inhibitors and chemotherapeutic agents. This systematic assessment aimed to clarify the breadth of kinase involvement. Researchers focused on summarizing established connections to genomic maintenance.
Main Results:
The strongest finding indicates that these kinases are inextricably linked to pathways guarding against genetic damage. Evidence shows that Aurora kinase A contributes to the G2 checkpoint through PLK1 activation. Both kinases prevent chromosome segregation errors by controlling the abscission checkpoint. Studies confirm that dysregulation triggers damage sensed by a p53-dependent postmitotic checkpoint. The literature provides a clear connection between these proteins and apoptotic pathways. Researchers report that these kinases influence the G1 checkpoint via p73 signaling. Data suggests that these proteins are essential for mitigating damage-induced micronuclei formation. The synthesis confirms that these kinases perform a myriad of non-mitotic functions.
Conclusions:
The authors propose that Aurora kinases serve as integral components of genomic stability maintenance. These proteins regulate various checkpoints to prevent errors during cell division. Researchers suggest that targeting these kinases could enhance the efficacy of existing cancer therapies. The evidence supports a synergistic relationship between kinase inhibition and DNA-damaging agents. This synthesis highlights the potential for novel therapeutic strategies in oncology. The authors emphasize that future work must clarify the specific mechanisms of these interactions. These findings provide a framework for understanding how cells manage genetic stress. The review underscores the importance of these kinases in preventing chromosomal instability.
The researchers propose that Aurora kinase A facilitates the G2 checkpoint by regulating PLK1 and CDC25B activation, whereas Aurora kinase B primarily manages the abscission checkpoint to prevent the formation of micronuclei during cell division.
The authors identify the p53 and p73 pathways as the primary mechanisms through which these kinases communicate with the G1 DNA damage checkpoint to ensure cellular integrity.
The authors state that these kinases are necessary to prevent chromosome segregation errors that arise specifically from DNA damage occurring during the mitotic phase.
The researchers utilize existing literature to synthesize evidence regarding how these kinases interact with apoptotic pathways and various DNA repair mechanisms to maintain genomic stability.
The authors observe that dysregulation of these kinases triggers genetic damage that is subsequently detected by a p53-dependent postmitotic checkpoint in the G1 phase.
The researchers propose that combining small-molecule inhibitors of these kinases with traditional DNA-damaging agents offers a promising strategy for improving cancer treatment outcomes.